Nuclear imaging and minimally invasive surgery in the management of hyperparathyroidism
is characterized by inappropriately elevated iPTH in presence of hypercalcaemia and both these may alter the functional status of hypothalmo-pituitary-adrenocortical (HPA) axis in these patients.
At this point, a diagnosis of primary hyperparathyroidism
was considered and localization studies were ordered to find the parathyroid adenoma.
The company has an advanced portfolio of new products targeting vitamin D deficiency and secondary hyperparathyroidism
in patients with moderate to severe chronic kidney disease and end stage renal disease.
Cinacalcet HCl is a new calcimimetic agent that has been used successfully for the treatment of primary and secondary hyperparathyroidism
in adults (10-12), but its use in adolescents with persistent primary hyperparathyroidism
has not been previously reported.
Sensipar: The metabolic disease drug has been approved to treat various parathyroid disorders and is in two trials to treat hyperparathyroidism
Hypercalcemia might be associated with hyperthyroidism alone or may occur as a manifestation of associated primary hyperparathyroidism
, although neither disorder has been hitherto adequately understood.
happens when one or more of your parathyroid glands located in your neck start secreting too much parathyroid hormone.
Bone Care International is a pharmaceutical company which is developing vitamin D-hormone therapies with improved safety and efficacy profiles for treatment of a) secondary hyperparathyroidism
associated with end-stage renal disease and pre-dialysis renal disease, b) osteoporosis, c) psoriasis, and d) cancers of the breast, prostate, and colon.
It is sometimes difficult to decide whether hyperparathyroidism
in FMEN1 is severe enough to need treatment, especially in a person who has no symptoms.
According to the report, the hyperparathyroidism
patient population is expected to increase over future years, primarily due to increasing Chronic Kidney Disease (CKD) prevalence and an increase in the elderly population.
Contract award: tlzp / 2-23 / 233/16/2015 purchase and delivery of a medicament for the treatment of secondary hyperparathyroidism